PharmGen Science Inc banner

PharmGen Science Inc
KRX:004720

Watchlist Manager
PharmGen Science Inc Logo
PharmGen Science Inc
KRX:004720
Watchlist
Price: 3 970 KRW -3.41%
Market Cap: ₩87.1B

PharmGen Science Inc
Investor Relations

PharmGen Science, Inc. engages in the development and production of medicaments. The company is headquartered in Hwaseong, Gyeonggi-Do. The Company’s products include antiepileptic agents, anti-inflammatory agents, antiphlogistic agents, central nervous system agents, urinary agents, antihistamine agents, antivirus agents, agents for bones, agents for livers, calcium agents, antibiotics, diabetes agents, respiratory agents, as well as over-the-counter (OTC) drugs, obesity drugs, health food and others. In addition, the Company is also engaged in the manufacturing, wholesale and retail distribution of functional cosmetics. The firm distributes its products within domestic market and to overseas markets.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
No Earnings Calls Available

Management

Lee Seung-Yeol
Chief Executive Officer
No Bio Available

Contacts

Address
GYEONGGI-DO
Hwaseong
50, Jeyakgongdan 2-gil, Hyangnam-eup
Contacts
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett